LIGAND PHARMACEUTICALS INCORPORATED Foreign Pre-Tax Income
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Foreign Pre-Tax Income of $32.53 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, foreign for fiscal 2025 was $32.53M, a 14.66% increase from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, foreign for fiscal 2024 was $28.37M, a 1766.64% increase from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations before income taxes, foreign for fiscal 2023 was $1.52M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Foreign 12 month |
|---|---|
| 2025-12-31 | $32.53M 10-K · filed 2026-02-27 |
| 2024-12-31 | $28.37M 10-K · filed 2026-02-27 |
| 2023-12-31 | $1.52M 10-K · filed 2026-02-27 |